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Strategies of Mesenchymal 
Invasion of Patient-derived Brain 
Tumors: Microenvironmental 
Adaptation
Junghwa Cha1, Seok-Gu Kang2 & Pilnam Kim1
The high mortality in glioblastoma multiforme (GBM) patients is primarily caused by extensive 
infiltration into adjacent tissue and subsequent rapid recurrence. There are no clear therapeutic 
strategies that target the infiltrative subpopulation of GBM mass. Using mesenchymal mode of 
invasion, the GBM is known to widely infiltrate by interacting with various unique components within 
brain microenvironment such as hyaluronic acid (HA)-rich matrix and white matter tracts. However, 
it is unclear how these GBM microenvironments influence the strategies of mesenchymal invasion. 
We hypothesize that GBM has different strategies to facilitate such invasion through adaptation 
to their local microenvironment. Using our in vitro biomimetic microenvironment platform for 
three-dimensional GBM tumorspheres (TSs), we found that the strategies of GBM invasion were 
predominantly regulated by the HA-rich ECM microenvironment, showing marked phenotypic changes 
in the presence of HA, which were mainly mediated by HA synthase (HAS). Interestingly, after inhibition 
of the HAS gene, GBM switched their invasion strategies to a focal adhesion (FA)-mediated invasion. 
These results demonstrate that the microenvironmental adaptation allowed a flexible invasion 
strategy for GBM. Using our model, we suggest a new inhibitory pathway for targeting infiltrative GBM 
and propose an importance of multi-target therapy for GBM, which underwent microenvironmental 
adaptation.
Invasion ability toward surrounding tissue in the progression of malignant tumors is a main cause for metastasis 
and relapse1. Tumor cell invasion is predominantly regulated by distinctive biophysical and biochemical stimuli 
originating from the complex network of extracellular matrix (ECM) in their microenvironment2,3. During tumor 
progression, dynamic ECM remodeling mediated by reciprocal interactions between the ECM and tumor cells 
leads to facilitate tumor invasion3. Understanding the mechanisms of interactions between infiltrative tumor 
cells and ECM microenvironment is essential for developing new therapeutic inventions for malignant tumors.
Tumor cells possess a broad pattern of invasion mechanism, such as individual and collective cell migration, 
in response to different conditions, thus efforts to understand how ECM composition, mechanical properties 
(e.g., stiffness or porosity), and topography influence on the mechanisms of tumor invasion have been ongoing 
for decades4–11.
Unlike other systemic tumor, malignant brain tumors, especially glioblastoma multiforme (GBM), exhibit 
unique features of invasion. GBM invades locally inside brain (micro-metastasis) and spreads in a single-cell 
level, rather than metastasizes to distant organs. Moreover, GBM cells barely penetrate the subarachnoid space 
or intravasate into the cerebral microvasculature12,13. Although GBM invasion is confined within the intracranial 
spaces, patients have poor prognosis. The pro-invasive microenvironment for GBM remains unclarified, as there 
are no plausible models that reflect the composition and structural elements of tumor microenvironment in 
pathophysiologically relevant configurations. It is necessary to investigate the microenvironmental influence of 
brain to understand the unique characteristics of GBM invasion.
In a single-cell level, different modes of cancer cell invasion seem to exist, including mesenchymal and 
amoeboid type. The mode of cell invasion has been classified based on the morphology of invasion pattern, the 
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molecular parameters, and the modification of ECM imposing by invading cells14. Unlike to the amoeboid mode, 
which is based on propulsive movement without proteolytic ECM remodeling, the mesenchymal mode involves 
focalized cell-ECM interactions and movement in a traction-dependent manner due to the cytoskeletal contrac-
tility. The focalized cell-ECM interaction leads to recruit ECM-degrading proteolytic enzymes to perform ECM 
remodeling and generate the path for invading cells15.
Numerous culture models, such as in vitro three-dimensional (3D) hydrogels, ex vivo organotypic brain slice 
cultures, and in vivo mouse models, have been used to study the cellular effects on microenvironment11,16–24. 
These research have indicated that the glioblastoma cells migrate individually with the mesenchymal mode of 
motility in a traction-dependent manner, so called saltatory migration25–27. In this process, the GBM cells generate 
a strong adhesion force at the focal contacts on ECM by intensively concentrating the integrins25. Simultaneously, 
they produce the proteases to degrade the local ECM components, by pulling and contracting the actin cytoskel-
eton to propel toward a newly developed invasion path28. For example, proteolytic enzymes including matrix 
metalloproteases (MMPs) are intensively involved in ECM remodeling at these focal sites25,29. For this reason, 
targeting the proteolytic process in mesenchymal movement of GBM cells has been highlighted as a promising 
therapy to inhibit wide invasion. However, treatment with MMP inhibitors (MMPIs) has limitations, which cause 
severe side effects including musculoskeletal pain and inflammation30. Furthermore, despite intensive efforts, 
there has been little improvement offered by the new therapeutic strategies.
In this context, the effects of the tumor microenvironment on GBM invasion must be understood as the 
unique and complex features of brain tumor are simultaneously considered. A biomimetic approach to con-
struct an environment relevant to brain tumor would be valuable in understanding the brain tumor biology and 
developing new therapeutic intervention. We hypothesized that GBM has different strategies of invasion that are 
involved in adapting to its local microenvironment to facilitate invasion. To test this hypothesis, we developed an 
in vitro biomimetic microenvironment platform that mimics the complex microenvironment of GBM in physio-
logically relevant configuration.
Results
Abnormal regulation of hyaluronic acid (HA)-related genes in GBM tissue. There are two major 
components of microenvironment around GBM that could regulate GBM behavior (Fig. 1A). As biophysical cues, 
tumor cells interact with pre-existing brain anatomy (e.g. white matter tracts), called Scherer’s structures13, which 
are important as invasion path of GBM cells26. In addition, the ECM provides biochemical stimuli and mutually 
interacts with tumor cells. Although the components of the ECM in brain tumor tissue have not been fully eluci-
dated yet, it has been reported that amorphous ECM at the invasive front of proliferating GBM is highly expressed 
such as glycosaminoglycans (GAGs), especially hyaluronic acid (HA)31–33, and they strongly up-regulated fibrous 
and adhesive ECM proteins, (e.g., collagen IV, fibronectin, and laminin)34.
To confirm the pathophysiologic gene regulation in GBM patients, we compared genomic expression of nor-
mal and GBM tumor tissue using the Gene Expression Omnibus (GEO) database. At the mRNA level, HA-related 
genes were abnormally regulated in GBM tumors, particularly those involved in HA metabolism (Fig. 1B)35. 
The encoded genes for HA-binding receptors, CD44 and RHAMM (receptors for HA-mediated motility), were 
up-regulated in tumorous condition, possibly due to HA overexpression, contributing to GBM invasiveness36. 
Moreover, the encoded gene for HA synthase (HAS), especially HAS2, was aberrantly up-regulated in tumor, 
relative to HAS genes in normal tissue, which was consistent that HAS overexpression has been shown to result in 
increased tumorigenic features37. By contrast, in case of HA degradable genes, the expression of hyaluronidases 
(HYALs), which are responsible for HA matrix catabolism, did not differ between normal and GBM samples, 
except HYAL2. However, in case of MMPs, the representative proteases MMP2 and MMP9 were highly increased 
in GBM tissue. In addition, we analyzed the focal adhesion (FA)-related genes, such as FA kinase (FAK) and 
vinculin, which are known to highly involve in providing the degrading sites during mesenchymal mode of GBM 
invasion. Whereas there was no change in FAK expression, vinculin expression was increased in GBM than in 
normal tissue (Fig. S1). These results indicated that the genes, particularly the up-regulated HA-related ones, were 
abnormally regulated in GBM tissue.
Formation of HA-COL semi-IPN hydrogel to construct HA-rich ECM environment. To investigate 
the effects of HA on GBM identified in the transcriptomic analysis, we prepared collagen (COL) and HA-COL 
semi-interpenetrating polymer network (semi-IPN) hydrogels to represent non-HA normal and HA-rich con-
ditions in brain tissue. Since COL hydrogel has fibrillar structures, it forms a well-organized interconnected net-
work. However, a cross-linked network cannot be solely formed in HA hydrogel due to a linear and long chain of 
HA. Therefore, we created a HA-COL semi-IPN hydrogel in which long HA chains were interpenetrated into a 
cross-linked COL network (Fig. 2A).
Various concentrations of HA solution were combined with 4 mg/ml COL hydrogel to optimize the HA-COL 
semi-IPN hydrogel. The most stable HA-COL semi-IPN gel was formed when using the 4 mg/ml HA, while 
higher concentrations of HA resulted in unstable mechanical features (Fig. S2A). Using scanning electron micros-
copy (SEM), the microscopic networks of COL and HA-COL semi-IPN hydrogels were observed (Fig. 2B). COL 
hydrogel exhibited thin, networked fibrils, while HA-COL semi-IPN hydrogel showed thickend fibrils, but there 
were no significant differences of porosity between two hydrogels. The moduli of COL and HA-COL semi-IPN 
hydrogels were measured to confirm the mechanical compatibility with brain tissue. Using the frequency sweep 
mode for the rheological analysis, the storage moduli (G’) were nearly consistent along all frequency ranges, 
showing higher values than loss moduli (G”) at each frequency. This indicated the stable and uniform forma-
tion of internal cross-linked polymer networks for both COL and HA-COL semi-IPN hydrogels (Fig. S2B). In 
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addition, the elastic moduli at 1 Hz of both hydrogel (COL: 78 Pa, HA-COL semi-IPN: 118 Pa; Fig. S2C) were 
comparable with that of brain tissue38.
To evaluate the structural stability of HA-COL semi-IPN hydrogel within liquid phase-solution (i.e. cell culture 
medium), we measured the amount of HA released from HA-COL semi-IPN during 72 hr cultivation using the carba-
zole reaction assay to detect the solubilized form of glucuronic acid, a major component of HA. The HA concentration 
was calculated based on the standard curve for HA using optical density (O.D.) (Fig. S3A). We collected and tested 
the medium every 24 hr, which showed no significant changes in O.D. over time (Fig. S3B). Moreover, HA-COL 
Figure 1. Pro-invasive factors within brain tumor microenvironment. (A) Schematic illustration of brain 
tumor-favorable microenvironment. Hyaluronic acid (HA)-rich extracellular matrix (ECM) and pre-existing 
brain anatomy (e.g. white matter tract). (B) Illustration of three major components in HA metabolism. 
Transcriptomic analysis of Gene Expression Omnibus (GEO) data for three major HA metabolic genes between 
normal brain tissue and GBM tissue: HA receptors (CD44, RHAMM), HA Synthases (HAS1, HAS2, and HAS3), 
and Hyaluronidase (HYAL1, HYAL2, HYAL3, and HYAL4). The normalized gene expression ranging from 0 
(no expression) and 1 (fully expression). Red bar indicates the statistical significance between normal and GBM 
tissue.
www.nature.com/scientificreports/
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Figure 2. Features of GBM within Hyaluronic acid (HA)-rich ECM environment. HA can be 
interpenetrating with a fibrillary, crosslinked collagen (COL) hydrogel, forming hyaluronic acid-collagen 
semi-interpenetrating polymer network (HA-COL semi-IPN). The patient-derived GBM cells were isolated 
with CD133 markers using flow cytometry, then labelled with green fluorescent protein (GFP). (A) Structural 
scheme for HA-COL semi-IPN as HA-rich ECM environment.(B) Scanning electron images of COL and HA-
COL semi-IPN matrices. Scale bar: 10 μ m. (C) The culture process of three-dimensional GBM tumorsphere 
(TS) in ECM matrix. (D) Increased relative expression of HA receptors, CD44 and RHAMM in GBM, cultured 
within non-HA (COL only) and HA-rich (HA-COL semi-IPN) environment. (n = 5~6; Asterisks indicate a 
significant difference by student’s t-test, *p < 0.05). (E) Normalized proliferation of GBM cultured in non-HA 
(COL only) and HA-rich (HA-COL semi-IPN) environment (red line: non-HA, yellow line: HA-rich) in a fold-
change. (F) Representative fluorescent images of invaded GBM TS within non-HA and HA-rich environment 
according to the time-variant. The invasiveness of GBM TS within HA-rich ECM environment was higher than 
one of GBM TS within non-HA environment.
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semi-IPN gel maintained their initial networked structures overtime without deformation in absence of cell-ECM 
interaction (Fig. S3C). These results confirmed that HA-COL semi-IPN was stable, despite high solubility of HA.
Influence of HA-rich environment on GBM. We observed the influence of an HA-rich environment on 
GBM using COL and HA-COL semi-IPN hydrogel as a non-HA and HA-rich matrices respectively. As 3D tumor 
masses can reflect in vivo biological configurations (Fig. 2C), we cultured spontaneously formed 3D tumorspheres 
(TSs) from patient-derived CD133-positive GBM cells in non-HA and HA-rich matrices. Genomic expression 
of HA receptors, CD44 and RHAMM were significantly higher in GBM TSs in HA-rich environment (Fig. 2D). 
Moreover, GBM TSs cultured in the HA-rich matrix proliferated more than those in the non-HA matrix (Fig. 2E). 
In addition, when we observed GBM invasion within both matrices in time-lapse, GBM TS showed more aggressive 
infiltration into the HA-rich matrix, than TS invasion within non-HA matrix (Fig. 2F, Supplementary videos 1, 2). 
At a single-cell level, we observed marked morphological differences in scattered cells within non-HA and 
HA-rich matrices using confocal microscopy. In HA-rich matrix, single GBM cells were round with thin tails, 
whereas cells in non-HA matrix were elongated (Fig. S4A,B). In addition, it was revealed that cells in HA-rich 
matrix had significantly lower tail-to-body ratios (Fig. S4C). In a dynamic aspect, we observed that for given time 
(6 h), the single GBM cell moved faster in HA-rich matrix, compared to cell in HA-free matrix (Fig. S4D). These 
results suggested that the HA-COL semi-IPN represented HA-rich environment of brain tumor tissue, promoting 
aggressive progression and invasion.
Influence of fibrous structures on GBM. We examined whether biophysical cue, such as brain histopa-
thology, could contribute to preferential infiltration at the invasive front in an HA-rich environment. To test this 
tissue interfacial invasion, we cultured GBM TSs in a submicron fiber-incorporated HA-COL semi-IPN matrix 
(Fig. 3A). Electrospun polycaprolactone (PCL) fibers, which mimic the representative Scherer’s structures, white 
matter tracts, had submicron-sized diameters (~3 μ m) with cylindrical morphology (Fig. S5A), which could 
induce in vivo-like GBM cell movement based on our previous research26.
Using Fast Fourier Transform (FFT), we analyzed that the profiles of fibers were composed of symmetric 
central narrow bands, indicating nearly high alignment (Fig. S5B). A radial summation of normalized pixel inten-
sities also confirmed nearly uniform fiber alignment, showing two dominant peaks at 90° and 270°, which repre-
sented symmetry (Fig. S5C).
F-actin was stained with rhodamine-conjugated phalloidin for observation. At the matrix-fiber interface, the 
F-actin of GBM cell was highly aligned and guided by the electrospun fibers, whereas the GBM TSs cultured 
without fibers exhibited randomized F-actin organization (Fig. 3B, Fig. S5D). In addition to the morphological 
changes, the fibrous structures influenced on the invasion dynamics of GBM TSs. At the invasive front, the scat-
tered cells disseminated in the direction of the fibers (Fig. S5E). As a key factor in brain tumor microenviron-
ment, we confirmed that the phenotypic characteristics of GBM TSs at the interfacial invasion front were largely 
dependent on the biophysical effects that mimic the pre-existing brain anatomic structures. Taken together, these 
results indicated PCL fibers-incorporated HA-COL semi-IPN hydrogel can be used as an effective in vitro biomi-
metic microenvironment platform.
Features of GBM in an in vitro biomimetic microenvironment platform. We investigated gene regu-
lation in GBM TSs using the biomimetic microenvironment platform, which is based on PCL fibers-incorporated 
HA-rich matrix. The expression profile was obtained from quantitative real-time (qRT) PCR analysis of GBM TSs 
cultured in the biomimetic platform (Fig. 3C, Fig. S6). As expected, intracellular signals related to HA metabolism 
were influenced by the presence of HA, showing the upregulation of HAS, especially HAS2. Conversely, there were 
no changes in HYAL expression. In particular, in contrast to the transcriptomic results, HYAL2 showed no expres-
sional change (Fig. 3C). The expression of MMP gene increased, whereas that of FAK was slightly downregulated 
in the platform (Fig. S6). These results were consistent with our transcriptomic analysis (see Fig. 1B). We con-
cluded that GBM TSs cultured in our model were influenced by the biomimetic microenvironment, significantly 
regulating their ECM-related gene expression.
HAS inhibition as a new therapeutic suggestion. HA had been proved to be not only a prominent 
component of the ECM in brain tumor microenvironment but also a driver of tumor malignancy31,35. Based on 
GEO analysis data, HA-related genes, especially CD44, HAS2 and HYAL2 were significantly upregulated in GBM 
tissue obtained from patients (see Fig. S1). These upregulated genes represent potential targets for brain tumor 
therapies. As CD44 is a multifunctional molecule involved in cancer proliferation, differentiation, migration, or 
angiogenesis, there have been efforts to target the CD44. However, there have been few reports on targeting met-
abolic genes such as HAS and HYAL to develop therapeutic agents.
Recent research using animal models has found that inhibition of HA synthesis yields effective results in treat-
ing malignant diseases39. Therefore, we investigated the effect of HA synthesis inhibition on GBM invasion in our 
model. We found that 4-methylumbelliferone (4-MU), or hymecromone that is already used as a bile therapy, 
inhibits production of glucuronic acid (Fig. S7A), which is a major component of HA. In addition, 4-MU is an 
approved drug in Europe and Asia and has been identified as a potential anti-cancer drugs, including pancreatic, 
breast, and liver cancer.
We observed the effect of HAS inhibition on TSs invasion for 72 hr by treating with 0, 0.1 and 1 mM of 4-MU 
(Fig. 4A). First, the GBM cells were allowed to invade for 12 hr and subsequently treated with 4-MU. In the 
HA-rich environment, 4-MU treated TSs showed low invasion compared with untreated TSs. Moreover, HAS 
inhibition significantly decreased TSs proliferation but not cell viability (Fig. 4B, Fig. S7B). When the TSs were 
treated with 4-MU at the beginning of the cell invasion (0 hr), little invasion also occurred in the presence of 
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4-MU (Fig. S8). In addition, to confirm the inhibition efficacy of 4-MU, we investigated the effect of HAS inhi-
bition on GBM invasion in absence of HA. GBM TSs within PCL fiber-incorporated COL matrix were allowed 
to invade 12 hr and then treated 4-MU with 0, 0.1 and 1 mM concentration. There were no significant effect 
of the HAS inhibition on 4-MU treated TSs in HA-free matrix, compared to TSs in the HA-rich environment 
(Fig. S9A). Moreover, the inhibition of HA synthesis did not influence on TSs proliferation (Fig. S9B). These 
results collectively indicated that the 4-MU treatment was significantly effective in presence of HA.
Figure 3. Features of GBM in in vitro biomimetic microenvironment platform. (A) The culture process of 
three-dimensional GBM tumorsphere (TS) in in vitro biomimetic microenvironment platform. (B) Morphological 
characteristics of GBM TSs within the in vitro biomimetic microenvironment platform. Fluorescent images of TSs 
along the electrospun fiber. (Blue: nucleus, Green: cytosol, Red: F-actin). (C) Relative expression of HA metabolic 
genes: synthetic genes (HAS) and enzymatic genes (HYAL) (n = 5~6; Asterisks indicate a significant difference by 
student’s t-test, **p < 0.001; no sign for Non-significant difference).
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Interestingly, with increasing 4-MU concentrations, the invaded GBM cells with sharper and thinner mor-
phologies dominantly began to invade along the direction of fiber (Fig. 4C). These results were confirmed by 
molecular profiles of GBM TS in presence of 4-MU treatment (Fig. 4D). Correlated to HA inhibition by 4-MU, 
HAS2 expression decreased in a dose-dependent manner. Consistent with morphological changes in GBM cells 
but in contrast to HAS2 expression, FAK and MMP2 expressions increased significantly and in proportional to 
4-MU concentration. By contrast, in HA-free matrix, HAS2 expression decreased in a dose-dependent manner, 
but FAK and MMP2 expressions showed no marked changes in spite of 4-MU treatment (Fig. S9C). Thus, we 
Figure 4. Inhibition of HAS as a new therapeutic suggestion. (A) The inhibition of HAS genes in 
4-methylumbelliferone (4-MU) treated GBM TSs within biomimetic environment after 72 hr invasion. 4-MU 
was treated after 12 hr invasion. Inset: 4-MU treated GBM TSs at 0 h. (B) Normalized proliferation of GBM 
in presence of 4-MU treatment in a fold-change. (A) Magnified immunofluorescent images for invaded GBM 
TSs in presence of 4-MU treatment. The 4-MU was treated at 12-hour after GBM invasion. Scale bar: 50 μ m. 
(C) Molecular expression profiles in presence of 4-MU. (n = 5~6; Asterisks indicate a significant difference 
statistically by student’s t-test, *p < 0.05; **p < 0.01; ***p < 0.001).
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revealed that in HA-rich environment, depletion of HA-dependent (especially HAS2) invasion activated other 
strategies mediated by FA with enzymatic process to adapt the microenvironment.
Discussion
In this study, we hypothesized that GBM might alter their strategies of mesenchymal mode of invasion within 
their local microenvironment. To confirm this, we developed a 3D biomimetic GBM microenvironment plat-
form that includes two major pro-invasive factors, a HA-rich ECM environment and the anatomical guidance of 
Scherer’s structure. The platform used in this study, enables to observe a modulation of invasion strategy of GBM 
through microenvironmental adaptation.
To investigate the GBM invasion in their microenvironmental context, we adopted HA-COL semi-IPN as 
HA-rich matrix and electrospun microfibers as brain anatomy-mimetic structures. In our platform, we could 
observe the phenotypic changes of GBM cells in response to the effect of HA-rich matrix, while being guided 
along a fibrous structure as interfacial invasion routes. Within the HA-rich matrix, the GBM cells were round, 
with low tail-to-body ratio, whereas cells were elongated along the fibrous structures, with high tail-to-body ratio, 
presenting distinct morphological difference in presence/absence of HA or fibers.
Next, we studied the microenvironmental influences on the motility of GBM TSs using our platform. 
It indicated that the motility of GBM TSs in HA-rich environment is faster than that of the TSs in HA-free 
matrix. According to the time-lapse observation, in HA-free and HA-rich matrices, the GBM TSs invaded in 
traction-mediated manner by developing and contracting thin, and finger-like structures, such as filopodia. 
Moreover, the GBM cells within HA-rich matrix experienced the rapid turnover of cytoskeletal reorganization 
during their movement. In case of GBM TSs invasion on the PCL fibers, the cells were locally influenced at the 
fiber-matrix interface, following the direction of fibers. GBM cells were simultaneously allowed to elongate their 
cytoskeletal structures along the fibers. These features observed in our platform were frequently reported by the 
histological samples from GBM patients12,40 with highly elongated morphology along pre-existing structures in 
the brain, such as white matter tracts and microvasculatures. Taken together, the distinctive morphologic and 
motile features of GBM TSs were reproduced in our platform.
Although phenotypes of GBM TSs were controlled by both biochemical (HA) and physical (fiber) cues, the 
molecular features of GBM cells in brain tumor-favorable environments were revealed to be mainly depend-
ent on the biochemical stimuli from HA according to our results. The local invasion of GBM is reported to be 
highly associated with HA32. In addition, HA-binding proteins such as CD44 and RHAMM, which mediate adhe-
sion onto HA, are known to contribute to invasive motility during GBM progression36. In company with highly 
expressed HA and their HA-binding receptors, the metabolic process of HA is also regulated abnormally for both 
anabolic (HA synthesis) and catabolic (HA degradation) processes. According to our results, HA production by 
HAS, especially HAS2 of GBM TSs was markedly activated during invasion into HA-rich ECM. Interestingly, the 
representative HA receptor, the CD44 gene has a close relationship with HAS, suggesting that crosstalk between 
two genes might stimulate the signal cascades for GBM invasion36. Based on both the GEO database and experi-
mental results, we confirmed that gene expression of HA receptors and HAS genes were up-regulated in tumorous 
conditions, suggesting the correlation with GBM infiltration. Therefore, we can suggest that GBM invasion is 
predominantly influenced by HA-rich ECM environments due to the high involvement of HA receptors and HAS 
in the infiltrating GBM.
Recently, anabolic HA genes, especially HAS2, have been identified as a potential therapeutic target due to 
their upregulation in tumorigenic conditions41,42, which was consistent with our analytical and experimental 
results. In response to HA increase, the synthetic process in HA metabolism presumably accelerated the positive 
feedback of HA production, contributing to HA-mediated tumorigenesis.
We thus suggested HAS gene as a new anti-invasion target. HA production was inhibited by 4-MU, which sig-
nificantly lowered the invasive and progressive abilities of GBM. This inhibition was only effective in presence of 
HA through depletion of HA-dependent (especially HAS2) invasion, which was confirmed by the HAS inhibition 
of GBM TSs in absence of HA. However, we observed that GBM tried to find an alternative way for infiltration. 
Even after blocking the major invasion route mediated by HAS, the 4-MU treated GBM TSs showed slight inva-
sion along the fibers at the matrix interface. Noticeably, when blocking HAS genes, the FAK genes, as well as the 
enzymatic MMP2 genes of GBM TSs showed increased expression in proportion to 4-MU concentrations. This 
indicated that GBM shifted their invasion strategy from a HAS2-mediated route to a FAK/MMP2-mediated one 
through microenvironmental adaptation. These results signified the presence of various strategies in GBM inva-
sion. Although the therapeutics prohibit the major routes of invasion mechanism in GBM, the GBM cells could 
find an alternative strategy, by adapting to other routes within the local microenvironment. Thus, it could be 
suggested that multi-target treatment is needed to block the various strategies of GBM invasion.
Meanwhile, the transcriptomic results suggested that HYAL genes, especially HYAL2, could be promising 
targets in treatment of GBM. However, the experimental results indicated no salient changes in HYAL expres-
sions, and the role of HYAL in tumor tissue remains unknown. According to conflicting reports, HYALs can act 
as either tumor promoters or suppressors depending on concentration41,43. However, in the tumor tissue, tumor 
cell-derived HYAL acted mainly as a tumor promoter, so careful consideration is needed to target HYAL as a 
therapy.
In summary, we presented strategies of mesenchymal GBM invasion based on an in vitro biomimetic microen-
vironment platform. These results partially clarified an unconventional and poorly understood model of brain 
tumor invasion as well as the response of GBM to the external environment during invasion. In addition, we 
observed a microenvironmental adaptation in response to blockade of HAS-mediated invasion route. The GBM 
cells, which was blocked by 4-MU, can readily replace their invasion strategy in FAK/MMP-mediated manner, 
which might contribute to evasion or resistance to anti-cancer treatments. Therefore, multi-target therapies might 
be promising and successful in treating infiltrative GBM.
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The microenvironment of brain tumor is more complex than we presented. GBM invasion plasticity is deter-
mined by intra-tumor heterogeneity and tumor-stromal reciprocity. Although our model might not have reflected 
all relevant conditions, we were able to target the major evading mechanisms of anti-invasion therapies using a 
biomimetic microenvironment platform for GBM cells. For tumor subpopulations with tumorigenic capacities 
and therapeutic resistance, future studies should focus on identifying new critical pro-invasive factors in brain 
tumors to determine other strategies of invasion.
Materials and Methods
Transcriptomic analysis of GEO data. The publicly available Gene Expression Omnibus (GEO) microar-
ray database was utilized to provide the expression profiles of the genes of interest. The GEO microarray data is 
based on GPL570 Affymetric GeneChip Human Genome U133 Plus 2.0 array. The Oncopression analysis tool 
(www.oncopression.com) was used to retrieve mRNA expression data for genes of interest from all available GBM 
tumor samples, including HA receptors (CD44, RHAMM), HA synthases (HAS1, HAS2, and HAS3), hyaluroni-
dases (HYAL1, HYAL2, HYAL3, and HYAL4), matrix metalloproteases (MMP2 and MMP9) and focal adhesion 
(FA)-related molecules (FAK and vinculin). The gene expression level is normalized by Universal exPression 
Codes (UPC), providing the relative values from 0 (no expression) to 1 (fully expression).
Preparation of collagen-hyaluronic acid semi-interpenetrating polymer network gels. We 
compare the COL and HA-COL semi-IPN hydrogel to represent normal (non-HA) and tumorous condition, 
respectively. For COL hydrogel as normal condition, COL solutions were prepared on ice immediately prior to 
use by diluting high-concentrated stock of COL type I from rat tail (Corning, USA) according to manufacturer’s 
protocol. Briefly, 8.23 mg/ml COL stock was diluted into 4.0 mg/ml collagen solution in distilled water. 1 M NaOH 
was added to bring the pH to 7.4 for cell culture. To fabricate of HA-COL semi-IPN, the solution of sodium 
hyaluronate (Lifecore Biomedical, USA, 1.01~1.8 MDa) with concentration of 4, 8 and 16 mg/ml were used for 
diluting solvent, instead of distilled water in the process of preparation44. Solutions were mixed thoroughly prior 
to hydrogel gelation into cell culture platform or rheology dishes. Both hydrogels were incubated at 37 °C for 1 h 
prior to addition of a superlayer of cell culture medium. For further inspection, the cross-sections of freeze-dried 
hydrogels were coated with platinum (Pt) and observed with conventional scanning electron microscopy (SEM, 
FEI, Netherlands).
Fabrication of electrospun PCL fiber. For mimicking the pre-existing structure of white matter tract, 
electrospinning technique was used to fabricate aligned fiber in sub-micron using biodegradable 15% poly-
caprolactone (PCL) polymer (Sigma-Aldrich, St Louis, MO, 440752). 15% PCL polymer were firstly melted in 
chloroform/N,N-dimethylformamide solvent (3:1 v/v ratio), purchased in Sigma-Aldrich (372978 and 227056, 
respectively). Using a syringe with 25-gauge blunt metal needle, the solubilized PCL polymer was jetted into 
the coverglass on the rotating mandrel (2500 rpm) at the 13kV of voltage, with the speed of 1.0 mL/h. The air 
gap between the needle and collector was set to 15 cm. The collected fibers were sterilized with PBS for 24h with 
ultraviolet rays for further experiment. Platinum (Pt)-coated electrospun fiber sample for conventional scanning 
electron microscopy (SEM, FEI, Netherlands) were prepared for visual inspection.
Cell culture. The patient-derived GBM stem cell line, GSC11 used in this study was kindly provided by Dr. 
F. Lang (Department of Neurosurgery, The University of Texas, MD Anderson Cancer Center, TX, USA). GSC11 
was CD133-positive GBM subpopulation sorted by flow cytometry and established as GBM stem cell line to 
spontaneously form the GBM tumorspheres (TSs)45,46. The TSs were transfected with green fluorescent protein 
(GFP) for easy visualization. The TSs were cultured in Dulbecco’s modified Eagle medium: nutrient mixture F-12 
(DMEM/F12) (Welgene, Korea) supplemented with 1% penicillin/streptomycin (Welgene), 1× B27 (Invitrogen, 
Carlsbad, CA, USA), 20ng/ml of basic fibroblast growth factor (bFGF, Invitrogen) and 20ng/ml of epidermal 
growth factor (EGF, Invitrogen). The cells were maintained at 37 °C in an atmosphere of 5% CO2 and 95% air. 
A confluent condition of TSs was passaged every 5 days (1:5 ratio) by dissociating with accutase (Invitrogen). A 
sphere around 10,000 cells were embedded within the platform for further experiment.
Invasion assay. For evaluating the invasive ability, the GFP-tagged TSs were embedded within 3D in vitro 
platform for 4 days. The visual inspection was performed using confocal microscope (Nikon, Japan), by scanning 
the whole depth of invaded TSs. The presented images were projected in the direction of depth (z-axis). The sig-
nal of GFP from TSs were recorded to quantify the invaded area by calculating the number of pixels. For further 
investigation for inhibition of invasion, the 4-methylumbelliferone (4-MU, Abcam, Cambridge, U.K.), so called 
hymecromone, is used to block the HA synthesis through the HAS.
Rheological analysis of hydrogel. To characterize the mechanical properties of COL and HA-COL 
semi-IPN hydrogels, the rheological features of hydrogels were analyzed with a rotating rheometer (Bohlin 
Advanced Rheometer, Malvern Instruments, Worcestershire, U.K.). After gelation, both hydrogels were placed 
between a 20 mm rotational detector and a parallel plate of the rheometer. The rheological features of hydrogels 
were characterized in a frequency sweep mode with a controlled stress. The storage modulus (G′ ) and loss mod-
ulus (G″ ) of the hydrogel samples were recorded in the frequency sweep mode at a given 1% strain within prede-
termined frequency ranges (0.079− 6.33 Hz). The elastic moduli for hydrogels were calculated at 1 Hz.
HA-releasing assay. To confirm the solubility of HA-COL semi-IPN hydrogel within liquid phase-solution, 
we measured the solubilized form of glucuronic acid, one of HA component, using conventional carbazole reac-
tion assay47. Briefly, we cultured GBM TSs within the HA-COL semi-IPN hydrogel and detected the released HA 
component in cell culture medium from the hydrogel during 72-hour incubation. At every 24-hour, we took the 
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supernatant from the cell culture medium as experimental samples. A serial dilutions of standard or samples 
of 50 ml (1 mg/ml) were placed in 1.5 ml Eppendorf tubes. 200 ml of a solution of 25 mM sodium tetraborate 
(Sigma-Aldrich) in sulfuric acid (Sigma-Aldrich) was added. The tubes were heated for 10 min at 100 °C in an 
oven. After cooling at room temperature for 15 min, 50 ml of 0.125% carbazole (Sigma-Aldrich) in absolute eth-
anol were carefully added. After heating at 100 °C for 10 min in an oven and cooling at room temperature for 
15 min, each sample was placed in 96-well plate to read in a microplate reader (Bio-Rad, Model 550) at a wave-
length of 550 nm.
Fast Fourier Transform (FFT) analysis of electrospun fiber. For quantified characterization of electro-
spun fiber, the Fast Fourier transform (FFT) analysis were used. The NIH ImageJ software supported by an oval 
profile plug-in was used to conduct 2D FFT analysis. The FFT analysis converts spatial information of image data 
into a mathematically defined frequency domain. This frequency domain plots the degree of pixel intensities in 
the spatial domain. The pixel intensities are summed along the peripheral direction for each angle of the circular 
projection from 0 to 360°. The summed pixel intensities for each radius are then plotted against the corresponding 
angle of acquisition to produce a graph of angle to arbitrary pixel intensity.
Immunocytochemistry. TSs grown on 3D in vitro biomimetic microenvironment platform were fixed in 
4% paraformaldehyde (Sigma-Aldrich) and permeabilized with 0.15% Triton X-100 (Sigma-Aldrich) for 30 min-
utes, respectively. F-actin was stained for 30 minutes using 2 mg/L rhodamine-conjugated phalloidin (Invitrogen). 
Nucleus was stained for 15 minutes using 2 mg/L DAPI (Invitrogen). After washing with PBS, the samples were 
preserved with Prolong Gold aqueous mounting medium (Invitrogen) before inspection by confocal microscopy 
(Nikon, Tokyo, Japan).
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). After 7 days, the gene expression of 
fully-invaded TSs within biomimetic environment was examined with qRT-PCR. Total RNA was extracted from 
each sample (at least n = 4~6 per each group) according to conventional RNA extraction protocol. Briefly, the 
samples were prepared with RNA isolation reagent and extracted with chloroform after 10 min, 14000 rpm cen-
trifugation. Reverse transcription was carried out using the cDNA Synthesis kit (Bio-rad, Richmond, CA, USA). 
qRT-PCR was performed using a PCR System (Bio-rad, Richmond, CA, USA) with PCR Master Mix (Toyobo, 
Japan). Gene expression of each marker was quantified using signal amplification of SYBR green (Bio-rad) for 
human CD44, human RHAMM, human hyaluronidase 1, 2 and 3, human hyaluronan synthase 1, 2 and 3, human 
matrix metalloproteinase 2, 9 and human glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The level of 
gene expression was determined with the comparative Ct method in which the target genes were normalized to 
the endogeneous reference (GAPDH). The forward/reverse sequences used for experiments was listed in Table 1.
WST-1 assay. We utilized the conventional WST-1 method with EZ-cytox assay (water-soluble tetrazolium 
salt method) to evaluate the cell proliferation and viability. Briefly, TSs were incubated with 10 μ l EZ-cytox solu-
tion for 3-hour. After the formation of formazan crystals, by confirming color change of the culture superna-
tant, the absorbance of the culture supernatant was measured using a microplate reader at 450 nm (Bio-Rad, 
Richmond, CA, USA). The proliferation and viability rates were measured using the value of optical density 
(O.D.), compared to non-reacted EZ-cytox solution. The value of O.D. was relatively calculated as a normalized 
fold-change along the time-variant.
Statistical analysis. Data are presented as the mean ± standard error of the mean (SEM). Levels of signif-
icance for comparisons between two independent samples were determined using the Student’s t-test. Groups 
were compared by one-way analysis of variance (ANOVA) with Tukey’s post-hoc test applied to significant main 
effects.
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